Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2091]

Telepathology in Malawi

Dr Coxcilly Kampani - UNC Project, Lilongwe, Malawi

Telepathology in Malawi ( Dr Coxcilly Kampani - UNC Project, Lilongwe, Malawi )

Assessing the best screening methods for HPV/cervical cancer in Africa

Dr Nomonde Mbatani - University of Cape Town, Cape Town, South Africa

Assessing the best screening methods for HPV/cervical cancer in Africa ( Dr Nomonde Mbatani - University of Cape Town, Cape Town, South Africa )

Chemoprevention in breast cancer and possible vaccine for prostate cancer

Dr Leslie Ford - National Cancer Institute, Rockville, USA

Chemoprevention in breast cancer and possible vaccine for prostate cancer ( Dr Leslie Ford - National Cancer Institute, Rockville, USA )

Response to rituximab induction is a predictive biomarker in post-transplant...

Prof Corrado Tarella - Istituto Europeo di Oncologia, Milano, Italy

Response to rituximab induction is a predictive biomarker in post-transplant lymphoproliferative disorder ( Prof Corrado Tarella - Istituto Europeo di Oncologia, Milano, Italy )

The impact of microbiota on the immune response

Dr Giorgio Trinchieri - Center for Cancer Research, Bethesda, USA

The impact of microbiota on the immune response ( Dr Giorgio Trinchieri - Center for Cancer Research, Bethesda, USA )

ASH 2015: Highlights in mantle cell lymphoma

Prof Simon Rule and Prof Steven Le Gouill

ASH 2015: Highlights in mantle cell lymphoma ( Prof Simon Rule and Prof Steven Le Gouill )

ASH 2015: Novel combination approaches for multiple myeloma

Prof Marivi Mateos, Prof Sagar Lonial, Dr Torben Plesner, Prof Meletios...

ASH 2015: Novel combination approaches for multiple myeloma ( Prof Marivi Mateos, Prof Sagar Lonial, Dr Torben Plesner, Prof Meletios Dimopoulos )

ASH 2015: Ibrutinib as first-line treatment for chronic lymphocytic leukaemia

Prof John Gribben and Prof Stilgenbauer

ASH 2015: Ibrutinib as first-line treatment for chronic lymphocytic leukaemia ( Prof John Gribben and Prof Stilgenbauer )

First targeted therapy for multiple myeloma effective against hard-to-treat...

Dr Torben Plesner - Vejle Hospital, University of Southern Denmark, Vejle...

First targeted therapy for multiple myeloma effective against hard-to-treat disease ( Dr Torben Plesner - Vejle Hospital, University of Southern Denmark, Vejle, Denmark )

Anti-Bcl2 therapy shows promise for relapsed/refractory multiple myeloma

Dr Shaji Kumar - Mayo Clinic, Rochester, USA

$Anti-Bcl2 therapy shows promise for relapsed/refractory multiple myeloma ( Dr Shaji Kumar - Mayo Clinic, Rochester, USA )$

Comment: Classification system based on cytogenetics and treatment response...

Dr Wendy Stock - University of Chicago, Chicago, USA

Comment: Classification system based on cytogenetics and treatment response identifies leukaemia patients with high-risk clinical features ( Dr Wendy Stock - University of Chicago, Chicago, USA )

Comment: Study identifies genetic variant that signifies higher risk for...

Dr Wendy Stock - University of Chicago, Chicago, USA

Comment: Study identifies genetic variant that signifies higher risk for avascular necrosis in children with acute leukaemia ( Dr Wendy Stock - University of Chicago, Chicago, USA )

More from ecancer